BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 29575150)

  • 1. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
    Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of the serum galactomannan and (1, 3)-β-D-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Cai X; Ni W; Wei C; Cui J
    Intern Med; 2014; 53(21):2433-7. PubMed ID: 25366000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.
    Yu Q; He J; Xing B; Li X; Qian H; Zhang H; Xu M; Peng H
    BMC Pulm Med; 2020 Apr; 20(1):89. PubMed ID: 32293386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis.
    Ahmad S; Al-Shaikh AA; Khan Z
    PLoS One; 2014; 9(6):e100524. PubMed ID: 24955575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
    Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis.
    Dai Z; Cai M; Yao Y; Zhu J; Lin L; Fang L; Li Z; Yi H; Chen B; Liang X
    Medicine (Baltimore); 2021 Apr; 100(14):e25233. PubMed ID: 33832082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The diagnostic performance of galactomannan detection for invasive pulmonary aspergillosis in non-neutropenic hosts].
    Lin PC; Lai QQ; Zhou Y; Ye JR; Wu Q; Chen CS; Li YP
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Dec; 39(12):929-933. PubMed ID: 27938542
    [No Abstract]   [Full Text] [Related]  

  • 10. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
    Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
    J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
    Pazos C; Pontón J; Del Palacio A
    J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of the combinations of bronchoalveolar lavage fluid galactomannan test and serum galactomannan test in invasive pulmonary aspergillosis].
    Liu L; Li J; Dong H; Jiang L; Song H; Zhang S; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):331-335. PubMed ID: 30914095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
    Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
    Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis.
    Lu Y; Liu L; Li H; Chen B; Gu Y; Wang L; Feng C; Chen C; Chen Y; Sun W; Cui X; Cao M; Tao Y; Zhong J; Zhong H; Ni Y; Cai Y; Song M; Liu X; Shi Y; Su X
    Clin Microbiol Infect; 2023 Jun; 29(6):797.e1-797.e7. PubMed ID: 36773771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests.
    Gao X; Chen L; Hu G; Mei H
    Ann Saudi Med; 2010; 30(3):193-7. PubMed ID: 20427934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.